Last updated on August 7th, 2023
Breast implants, considered medical devices by the U.S. Food and Drug Administration, are used in one of the most requested cosmetic surgical procedures in the country. In reconstruction surgeries, implants can rebuild breast tissue after a mastectomy, which may have been part of a woman’s breast cancer treatment. But what happens when breast implants actually cause cancer?
The FDA issued a statement on March 21, 2017, regarding breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), in which it concurs with the World Health Organization that BIA-ALCL is a rare T-cell lymphoma that can develop following breast implants. Data suggests that BIA-ALCL occurs more frequently with implants that have textured surfaces rather than smooth ones.
As of January 5, 2020, the FDA has received a total of 733 medical device reports (MDRs) of BIA-ALCL, including 33 deaths. More than 524 reports include information on the implant surface, with 496 reported to be textured implants and 28 reported to be smooth implants. Additionally, 447 reported implants were filled with silicone gel while 248 were filled with saline.
The FDA first identified an association between breast implants and lymphoma in 2011. At that time, the number of known cases of ALCL was limited, so it wasn’t possible to determine any factors that increased the risk.
In the past few years, the FDA has continued to review MDRs and current medical literature, as well as data from the Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma (ALCL) Etiology and Epidemiology (PROFILE Registry). In 2016, there were several advances in defining the disease, including the designation from the World Health Organization. Additionally, professional organizations such as the Plastic Surgery Foundation and the National Comprehensive Cancer Network published information to help physicians understand the disease, its symptoms, and its treatment.
Like the U.S., the Australian Therapeutic Goods Administration issued a report in 2020 about cases and deaths from BIA-ALCL. None of the cases involved smooth breast implants. The regulatory body estimated the risk of developing BIA-ALCL to be between 1-in-1,000 and 1-in-10,000 women with breast implants.
In France, the National Agency for Medicines and Health Products Safety has asked manufacturers of textured breast implants to perform biocompatibility testing and report their findings within a year, so it can better be determined how living tissues react to textured implants.
In the U.S., two types of breast implants are approved for sale: saline-filled and silicone gel-filled. While both types have a silicone outer shell, they vary in size, shell thickness, shell surface texture, and shape.
Data on the latest MDRs in the U.S. related to BIA-ALCL includes the following:
Most recent studies suggest that women with breast implants have a very low but increased risk of developing ALCL compared to women who do not have breast implants. To treat BIA-ALCL, the implant and the capsule surrounding the implant are removed. Some cases require chemotherapy and radiation.
However, BIA-ALCL generally has only been identified in patients with late-onset symptoms such as pain, lumps, swelling, or asymmetry. The FDA does not recommend prophylactic breast implant removal in patients without symptoms or other abnormalities.
If you have breast implants now, the FDA says there’s no need to change your routine medical care and follow-up. You should, however, make sure to follow your doctor’s instructions on monitoring your implants. If you notice any changes, contact your healthcare provider immediately. Routine mammography screenings also are important, while periodic magnetic resonance imaging (MRI) should be done if you have silicone gel-filled implants to detect ruptures as recommended by your health care provider. The first MRI should occur three years after implant surgery, and every two years thereafter.
If you don’t have breast implants but are considering surgery, educate yourself and talk to your doctor about the benefits and risks of textured-surfaced versus smooth-surfaced implants. It’s important to know before going into surgery that breast implants are not lifetime devices, and the longer a woman has them, the more likely she is to develop complications that may require additional surgery, such as ruptures or scar tissue squeezing the implant.
All confirmed cases of ALCL in women with breast implants should be reported through the FDA’s MedWatch Program.
If you’ve done your research and have been injured by an implant, our experienced defective products attorneys may be able to help you get the compensation you deserve. Each approved breast implant sold in the U.S. has FDA Summary of Safety and Effectiveness Data, which provides risks, warnings, and studies associated with the FDA approval of the device. You’ll want to look into the frequency of complications, such as those that lead to further surgeries.
Similarly, you should have a good doctor. Breast augmentation and reconstruction are life-changing surgeries. While surgeons must evaluate the shape, size, surface texture, and placement of the implant and the incision site for each woman, sometimes they can make mistakes. Our experienced medical malpractice attorneys can review your case for potential damages at no cost related to breast implants and cancer.
If you live in Ohio, Indiana, or Kentucky, contact us today for a free, no-obligation consultation.
In a class action, all of the plaintiffs suffered similar damage from the same source. Mass tort suits are aggregations of a large group of plaintiffs making similar claims. Read more here.
The first step upon encountering a defective toy is to seek medical help if an injury has occurred. Following that, your best bet will be to speak with an experienced defective products attorney as soon as possible. See more about toy recalls and claims here.
You must file a product liability claim within two years after you actually learn (or should have known) of the injury or harm upon which your claim is based. Read more about defective drug lawsuits here.
In many cases, you may be able to recover for any damages you have sustained, including your medical expenses, lost income, loss of quality of life, and physical and emotional pain and suffering. Read more about defective retail products here.
I am glad I chose DGMS for my personal injury case ! Sometimes I would call for update’s multiple times and yet they were patient and understanding. Crystal has done a phenomenal job thus far. Mr. Dominic Z. has done an awesome job as well with follow-up emails and ensuring we get the best results. I look forward to the end result as they are determined to get the best.
This will be the second review I have written. Can not say enough about Mr David Marquis, he has went above and beyond for me with my case. From day one, he has worked very hard for me to ensure that I would get what I was deserved. Also, his paralegals, Amy Smith and Allison was a God send. Whenever I had a question, they would get back with me within minutes.
I would highly recommend you to anyone. Thank you Mr Marquis and your staff for all you have done for me.
Mr Bruder and his assistants were extremely professional and knowledgeable. They kept me informed on the progress of my case. After all was done I received a settlement that was fair and reasonable. Would recommend their services 100%
This page has been written, edited, and reviewed by a team of legal writers following our comprehensive editorial guidelines. This page was approved by Founding Partner, Doug Mann who has more than 20 years of legal experience as a practicing personal injury attorney.
If you or a loved one has been seriously injured, please fill out the form below for your free consultation or call us at 1.937.222.2222
